Skip to content

Diagnostic Accuracy of Quantitative Flow Ratio

Diagnostic Accuracy of Quantitative Flow Ratio for Hemodynamic Assessment of Coronary Artery Stenosis: Prospective Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06305572
Enrollment
280
Registered
2024-03-12
Start date
2019-07-30
Completion date
2023-09-26
Last updated
2024-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Brief summary

The aim of this study was to investigate the accuracy of quantitative flow ratio (QFR) for predicting fractional flow reserve (FFR) ≤0.80 in an independent core laboratory.

Detailed description

FFR is an invasive physiological index used to define coronary stenosis that causes ischemia. Several studies have suggested that FFR-based percutaneous coronary intervention (PCI) can reduce adverse clinical outcomes compared to angiography-guided PCI. Although FFR is highly recommended in current guidelines, it is underused in real-world practice. QFR is a method for evaluating fractional flow reserve FFR without the use of an invasive coronary pressure wire or pharmacological hyperemic agent. The aims of this study were: 1. To investigate diagnostic accuracy of angiography-based QFR for hemodynamic assessment of coronary artery stenosis compared to pressure wire-based FFR. 2. To compare the diagnostic performance of QFR versus % diameter stenosis (DS) in identifying physiologically significant coronary artery disease (CAD) using FFR as the reference standard. 3. To identify factors affecting QFR accuracy. 4. To compare the coronary CT data with QFR.

Interventions

DIAGNOSTIC_TESTQFR

Patients suspected with CAD undergoing diagnostic coronary angiography with an indication for to perform invasive FFR were included. QFR was analyzed in an independent core laboratory (Uijeongbu Eulji Medical Center) using the software package QAngio XA 3D 2.1 (Medis Medical Imaging Systems, Leiden, the Netherlands).

Sponsors

Inje University Ilsan Paik Hospital
CollaboratorOTHER
Keimyung University Dongsan Medical Center
CollaboratorOTHER
Ulsan Medical Center
CollaboratorOTHER
Sejong General Hospital
CollaboratorOTHER
Chosun University Hospital
CollaboratorOTHER
Severance Hospital
CollaboratorOTHER
Ulsan University Hospital
CollaboratorOTHER
Uijeongbu Eulji Medical Center
CollaboratorUNKNOWN
Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients suspected with CAD undergoing diagnostic coronary angiography with an indication for to perform invasive FFR

Exclusion criteria

* Suboptimal angiographic image quality for QFR analysis * Primary myocardial or valvular disease * Left ventricular ejection fraction ≤40% * Patients with cardiogenic shock

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic accuracy of QFRthrough study completion, an average of 1 yearDiagnostic accuracy of QFR (≤0.80 or \>0.80) to determine hemodynamically significant coronary stenosis using invasive FFR (≤0.80 or \>0.80) as a reference standard

Secondary

MeasureTime frameDescription
Sensitivity of QFRthrough study completion, an average of 1 yearSensitivity of contrast QFR to predict FFR lower than 0.8
Specificity of QFRthrough study completion, an average of 1 yearSpecificity of contrast QFR to predict FFR lower than 0.8
Correlationthrough study completion, an average of 1 yearCorrelation between QFR and FFR

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026